Surgeons: Ravi Munver and Ronald Boris

Moderator/Discussant: Ketan Badani


Dr. Ravi Munver

Dr. Munver is Vice Chair and Chief of Minimally Invasive and Robotic Urologic Surgery in the Department of Urology at Hackensack University Medical Center and is Professor of Urology at Hackensack Meridian School of Medicine. He is the founding Director of the Hackensack University Medical Center Robotic and MIS Fellowship Program.

Dr. Munver received his medical education at Cornell University Medical College and completed residency training at Duke University Medical Center. He received advanced fellowship training in robotic, laparoscopic, and endoscopic surgery at New York-Presbyterian Hospital/Weill Cornell Medical Center.

Dr. Munver is a passionate academician and educator. He has been teaching medical students and residents for more than 18 years and received and the Golden Apple Award for excellence in teaching.

Dr. Munver is known for his compassionate care with patients and received the Gold DOC Award for Humanism in Medicine.

Dr. Ronald S. Boris, M.D.

Dr. Boris is board certified in urology and an Associate Professor of Urology at Indiana University School of Medicine. He received his Bachelor of Science from the University of Michigan and his masters in Biotechnology from Northwestern University. Dr. Boris graduated with high honors from medical school at Wayne State University and was awarded membership to the Alpha Omega Alpha honor society. He completed his urology residency at Henry Ford Hospital’s Vattikuti Urology Institute. He completed his urologic oncology fellowship at the National Cancer Institute at the National Institutes of Health where he performed complex kidney and adrenal-sparing surgery using both open and minimally invasive techniques.

Dr. Boris specializes in urologic oncology focusing on prostate, kidney, adrenal, and bladder cancer utilizing minimally invasive techniques whenever feasible. He has special interest in hereditary kidney cancer and multifocal renal masses and runs the genetic kidney cancer program at IU Simon Cancer Center. Dr. Boris has published extensively in the fields of kidney, prostate, and minimally invasive urologic surgery.

Dr. Ketan K. Badani

Dr. Ketan K. Badani is the Vice Chair of Urology and Robotic Operations at Mount Sinai Health System in New York. Dr. Badani has performed nearly 4,000 robotic procedures in his career, placing him in the top 1% of urologists worldwide for kidney and prostate surgery. He is one of the preeminent practitioners in the world for robotic partial nephrectomy for complex kidney tumors.

Dr. Badani is the author of over 150 peer reviewed publications and has presented more than 400 abstracts at national and international meetings. He leads innovative clinical trials, feasibility and safety studies of new technology, and health related quality of life outcomes research. He has pioneered the field of robotic urologic surgery with several of the early, fundamental publications on robotic surgery for prostate, kidney and bladder cancer. Analysis of robotic techniques during surgery to improve patient outcome has been a paramount focus in my recent work and efforts to improve surgical and oncologic outcome. Specifically, Dr. Badani has developed the First Assistant Sparing Technique (F.A.S.T.) which is utilized during robotic partial nephrectomy which specifically involves intracorporeal placement of sutures and bulldog clamps prior to clamping and tumor. This technique is published in the Journal of Endourology and reduces reliance on the first assistant and has been shown to lead to a shorter operation and shorter ischemia time for patients undergoing nephron sparing surgery. Dr. Badani is also an editor and/or reviewer for numerous academic journals including Cancer, Journal of Urology, Urologic Oncology, Journal of Endourology, among others.

In addition to surgery, Dr. Badani leads innovative research projects in the field of kidney cancer. He currently studies the optimization of MRI imaging data to predict long-term outcomes after treatment. Dr. Badani is also studying the role of recent advanced technology such as virtual reality and 3D modelling to help better understand the specific anatomy of each patient and apply that to planning the surgery to optimize the outcome. Another area of research focus is a clinical trial to study a novel medication for advanced and metastatic kidney cancer.